Table 1 Demographic and clinical characteristics of TNBC patients included in this analysis
|  | NRC (n = 8) | ERC (n = 4) | Total (n = 12) |
|---|---|---|---|
Age | |||
 Mean (SD) | 51.4 (11.0) | 55.8 (13.1) | 52.8 (11.3) |
 Range | 36–70 | 40–67 | 36–70 |
Menopausal status | |||
 Peri | 1 (12.5%) | 0 (0.0%) | 1 (8.3%) |
 Post | 4 (50.0%) | 3 (75.0%) | 7 (58.3%) |
 Pre | 3 (37.5%) | 1 (25.0%) | 4 (33.3%) |
T stage | |||
 T2 | 3 (37.5%) | 2 (50.0%) | 5 (41.7%) |
 T3 | 5 (62.5%) | 2 (50.0%) | 7 (58.3%) |
N stage | |||
 N0 | 6 (75.0%) | 3 (75.0%) | 9 (75.0%) |
 N1 | 2 (25.0%) | 1 (25.0%) | 3 (25.0%) |
M stage | |||
 M0 | 8 (100.0%) | 4 (100.0%) | 12 (100.0%) |
Race | |||
 NA | 0 (0.0%) | 1 (25.0%) | 1 (8.3%) |
 American Indian or Alaska Native | 1 (12.5%) | 0 (0.0%) | 1 (8.3%) |
 Caucasian | 7 (87.5%) | 3 (75.0%) | 10 (83.3%) |